Partial Chest Wall Radiation Therapy for Breast Cancer

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Stony Brook Cancer Center, Stony Brook, NY
Breast Cancer+5 More
Partial Chest Wall Radiation Therapy - Radiation
Eligibility
18+
Female
What conditions do you have?
Select

Study Summary

The standard treatment for breast cancer when cancer cells were found near or within the margins of the tissue that is removed during breast surgery, is radiation of the entire chest wall. This may be considered overtreatment since the only reason for doing so is that cancer cells were near or in the margins of the breast tissue that was removed. In this study, the amount of radiation treatment will be limited to the area where the remaining cancer cells were found after surgery. The purpose of this study is to find out if partial chest wall radiation therapy is as good as whole chest wall radiation therapy in reducing the risk of breast cancer cancer coming back.

Eligible Conditions

  • Breast Cancer
  • Breast
  • DCIS
  • Neoplasms

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

4 Primary · 0 Secondary · Reporting Duration: 5 years

3 months
Acute toxicity
5 years
Breast cancer recurrence
Delayed toxicity
Surgical complications

Trial Safety

Safety Progress

1 of 3

Trial Design

1 Treatment Group

Radiation Treatment
1 of 1
Experimental Treatment

25 Total Participants · 1 Treatment Group

Primary Treatment: Partial Chest Wall Radiation Therapy · No Placebo Group · Phase < 1

Radiation Treatment
Radiation
Experimental Group · 1 Intervention: Partial Chest Wall Radiation Therapy · Intervention Types: Radiation

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 5 years
Closest Location: Stony Brook Cancer Center · Stony Brook, NY
Photo of new york 1Photo of new york 2Photo of new york 3
2017First Recorded Clinical Trial
2 TrialsResearching Breast Cancer
9 CompletedClinical Trials

Who is running the clinical trial?

Stony Brook UniversityLead Sponsor
193 Previous Clinical Trials
34,562 Total Patients Enrolled
5 Trials studying Breast Cancer
275 Patients Enrolled for Breast Cancer
Alexander Stessin, MD PhDPrincipal InvestigatorStony Brook University

Eligibility Criteria

Age 18+ · Female Participants · 5 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have undergone a mastectomy.
Presence of cancer cells on or close to surgical margins.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.